Pharma Stocks
-
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 2.8% in the morning session after Wells Fargo downgraded the…
Read More » -
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance
Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be…
Read More » -
Q1 2026 beat, raised outlook and steady dividend attract fresh attenti
GSK plc has surprised the market with better-than-expected Q1 2026 results, a guidance increase and a maintained dividend, putting the…
Read More » -
earnings momentum and US injectables footprint in fo
Generic drug maker Hikma Pharmaceuticals PLC has been drawing attention with recent earnings, a solid injectables pipeline and growing US…
Read More » -
Towa Pharmaceutical (TSE:4553) Valuation After Goodwill Impairment And FY2027 Recovery Outlook
Goodwill impairment hits guidance while dividend and FY2027 outlook steady Towa Pharmaceutical (TSE:4553) drew investor attention after announcing a large…
Read More » -
China trial update keeps pipeline in focus
AstraZeneca plc drew fresh investor attention after a May 11, 2026 trial update showed its real-world sinus surgery study in…
Read More » -
A Look At Lexicon Pharmaceuticals (LXRX) Valuation After Improved Q1 Revenue And Narrowed Net Loss
Lexicon Pharmaceuticals (LXRX) is back in focus after first quarter results showed revenue of US$21.1 million versus US$1.26 million a…
Read More » -
How Strong UGN-103 Phase 3 Durability Data At UroGen Pharma (URGN) Has Changed Its Investment Story
Earlier in May 2026, UroGen Pharma reported that UGN-103 achieved a 94.5% six-month durability of response in Phase 3 UTOPIA,…
Read More » -
Regulatory setback, sharp drop and rising short interest
Vanda Pharmaceuticals shares came under heavy pressure after a regulatory setback announcement and are now facing rising short interest. What…
Read More » -
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Recent Share Price Volatility
Why Amylyx Pharmaceuticals Stock Is On Investors’ Radar Amylyx Pharmaceuticals (AMLX) has drawn fresh attention after recent trading saw the…
Read More »